Restenosis After Coronary and Peripheral Intervention: Efficacy and Clinical Impact of Cilostazol

Annals of Vascular Surgery - United States
doi 10.1016/j.avsg.2016.08.050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Impaired Digital Reactive Hyperemia and the Risk of Restenosis After Primary Coronary Intervention in Patients With Acute Coronary Syndrome

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2014English

Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment

Cardiology Research
Cardiovascular MedicineCardiology
2016English

Antioxidants and Prevention of Restenosis After Directional Coronary Atherectomy Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

The Prognostic Value of IL-8 for Cardiac Events and Restenosis in Patients With Coronary Heart Diseases After Percutaneous Coronary Intervention

Japanese Heart Journal
2003English

Interleukin 10: A New Risk Marker for the Development of Restenosis After Percutaneous Coronary Intervention

Genes and Immunity
ImmunologyGenetics
2006English

Clinical Significance of the Levels of Hmgb1 Before and After Percutaneous Coronary Intervention

Heart
Cardiovascular MedicineCardiology
2012English

Candidate Genetic Markers and the Risk of Restenosis After Coronary Angioplasty

Clinical Science
Medicine
2004English

Clinical Impact and Predictors of Carotid Artery In-Stent Restenosis

Journal of Neurology
Neurology
2012English

Predictors of In-Stent Restenosis in Patients Undergoing Percutaneous Coronary Intervention

Demiroğlu Bilim University Florence Nightingale Journal of Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy